The site of the Media Sphera Publishers contains materials intended solely for healthcare professionals.
By closing this message, you confirm that you are a certified medical professional or a student of a medical educational institution.

Login
EN
+7 (495) 482-4118
+7 (495) 482-4329
+8 800 250-18-12
  • (toll-free number for subscriptions)
    Mon-Fri from 10 a.m. to 6 p.m.

  • © 1998-2026
+7 (495) 482-43-29
EN
All journals
Journal
Year
Year
Search result: 0

Gromova E.G.

Blokhin National Medical Oncology Research Center

Extracorporeal detoxification in cancer patients

Authors:

Gromova E.G.

More about the authors

Journal: Russian Journal of Anesthesiology and Reanimatology. 2020;(5): 70‑76

DOI: 10.17116/anaesthesiology202005170

Read: 3052 times

Download PDF (RU)
Contact the author
Table of contents

EXTRACORPOREAL DETOXIFICATION IN CANCER PATIENTS
EXTRACORPOREAL DETOXIFICATION IN CANCER PATIENTS

To cite this article:

Gromova EG. Extracorporeal detoxification in cancer patients. Russian Journal of Anesthesiology and Reanimatology. 2020;(5):70‑76. (In Russ.)
https://doi.org/10.17116/anaesthesiology202005170

 
МСФ на ЯМ
Использование инфографики авторами научных работ
Close metadata
Recommended articles:
The first expe­rience of using a device for sele­ctive hemo­sorption of lipo­polysaccharide “Toxipak 300” in the treatment of patients with septic shock. Russian Journal of Anesthesiology and Reanimatology. 2025;(3):64-69
Evaluation of biochemical onco­logical markers and dermatoscopic picture in patients with tumor-associated loca­lized scle­roderma. Russian Journal of Clinical Dermatology and Vene­reology. 2025;(2):153-159
Abstract:

The modern approaches to extracorporeal detoxification in intensive care of cancer patients are reviewed in the article. Life-threatening disorders of homeostasis in these patients is a leading cause of reduced effectiveness of treatment of the underlying disease and increased mortality. Moreover, these disorders may be the result of decompensation of comorbid diseases or develop at any stage of treatment of cancer. The authors analyzed the methodology of surgical and drug treatment of cancer patients with end-stage chronic renal failure receiving hemodialysis. Data on modern extracorporeal detoxification methods in patients with paraproteinemic hemoblastoses and advanced release of free light chains of immunoglobulins are presented. The achievements of recent years in intensive therapy of sepsis following cancer are presented. The authors consider special indications for emergency extracorporeal detoxification in cancer patients without classical signs of organ decompensation. Perspective developments in extracorporeal detoxification issues including combination with antitumor treatment are indicated.

Keywords:

extracorporeal detoxification
cancer patients
paraproteinemic hemoblastoses
free light chains of immunoglobulins
paraneoplastic syndrome
tumor lysis syndrome
ESRD

Authors:

Gromova E.G.

Blokhin National Medical Oncology Research Center

Received:

15.06.2020

Accepted:

22.07.2020

Close metadata

References:

  1. Schellongowski P, Sperr WR, Wohlfarth P, Knoebl P, Rabitsch W, Watzke HH, Staudinger T. Critically ill patients with cancer: chances and limitations of intensive care medicine — a narrative review. ESMO Open. 2016; 1(5):e000018. https://doi.org/10.1136/esmoopen-2015-000018
  2. Williams SM, Killeen AA. Tumor Lysis Syndrome. Archives of Pathology and Laboratory Medicine. 2019;143(3):386-393.  https://doi.org/10.5858/arpa.2017-0278-rs
  3. Gromova EG. Expediency of extracorporeal hemocorrection in cancer patients with paraneoplastic syndromes. Vestnik intensivnoj terapii. 2016;1:17-20. (In Russ.).
  4. Ricci SB. Therapeutic possibilities of techniques of extracorporeal blood circulation in oncology. Medical Hypotheses. 2012;78(1):1-3.  https://doi.org/10.1016/j.mehy.2011.09.026
  5. Benoit DD, Hoste EA, Depuydt PO, Offner FC, Lameire NH, Vandewoude KH, Dhondt AW, Noens LA, Decruyenaere JM. Outcome in critically ill medical patients treated with renal replacement therapy for acute renal failure: comparison between patients with and those without haematological malignancies. Nephrology, Dialysis, Transplantation. 2005;20(3): 552-558.  https://doi.org/10.1093/ndt/gfh637
  6. Soares M, Salluh JI, Carvalho MS, Darmon M, Rocco JR, Spector N. Prognosis of critically ill patients with cancer and acute renal dysfunction. Journal of Clinical Oncology. 2006;24(4):4003-4010. https://doi.org/10.1200/JCO.2006.05.7869
  7. Darmon M, Ciroldi M, Thiery G, Schlemmer B, Azoulay E. Clinical review: Specific aspects of acute renal failure in cancer patients. Critical Care (London, England). 2006;10(2):211.  https://doi.org/10.1186/cc4907
  8. Lameier NH, Flombaum CD, Moreau D, Ronco C. Acute renal failure in cancer patients. Annals of Medicine. 2005;37(1):13-25.  https://doi.org/10.1080/07853890510007205
  9. Kang E, Park M, Park PG, Park N, Jung Y, Kang U, Kang HG, Kim DK, Oh KH, Joo KW, Kim YS, Yoon HJ, Lee H. Acute kidney injury predicts all-cause mortality in patients with cancer. Cancer Medicine. 2019;8(6):2740-2750. https://doi.org/10.1002/cam4.2140
  10. Darmon M, Thiery G, Ciroldi M, Porcher R, Schlemmer B, Azoulay É. Should dialysis be offered to cancer patients with acute kidney injury? Intensive Care Medicine. 2007;33(5):765-772.  https://doi.org/10.1002/cam4.2140
  11. Maccariello E, Valente C, Nogueira L, Bonomo H Jr, Ismael M, Machado JE, Baldotto F, Godinho M, Rocha E, Soares M. Outcomes of cancer and non-cancer patients with acute kidney injury and need of renal replacement therapy admitted to general intensive care units. Nephrology, Dialysis, Transplantation. 2011;26(2):537-543.  https://doi.org/10.1093/ndt/gfq441
  12. Knudsen LM, Hjorth M, Hippe E. Renal failure in multiple myeloma: reversibility and impact on the prognosis. Nordic Myeloma Study Group. European Journal of Haematology. 2000;65(3):175-181.  https://doi.org/10.1034/j.1600-0609.2000.90221.x
  13. Sakhuja V, Jha V, Varma S, Joshi K, Gupta KL, Sud K, Kohli HS. Renal involvement in multiple myeloma: a 10-year study. Renal Failure. 2000; 22(4):465-477.  https://doi.org/10.1081/jdi-100100888
  14. Iggo N, Winearls CG, Davies DR. The development of cast-nephropathy in multiple myeloma. QJM: Monthly Journal of the Association of Physicians. 1997;90(11):653-656.  https://doi.org/10.1093/qjmed/90.11.653
  15. Clark WF, Stewart AK, Rock GA, Sternbach M, Sutton DM, Barrett BJ, Heidenheim AP, Garg AX, Churchill DN; Canadian Apheresis Group. Plasma exchange when myeloma presents as acute renal failure: A randomized controlled trial. Annals of Internal Medicine. 2005;143(11):777-784.  https://doi.org/10.7326/0003-4819-143-11-200512060-00005
  16. Gromova EG, Zeynalova PA, Lyubimova NV, Timofeev YuS, Kushlinsky NE, Semenova AA, Lunin VV, Klyuchagina YuI. The experience of free light chains of immunoglobulin elimination in patients with monoclonal gammopathies. Onkogematologiya. 2019;14(2):8-12. (In Russ.). https://doi.org/10.17650/1818-8346-2019-14-2-8-12
  17. Danai PA, Moss M, Mannino DM, Martin GS. The epidemiology of sepsis in patients with malignancy. Chest. 2006;129(6):1432-1440. https://doi.org/10.1378/chest.129.6.1432
  18. Soares M, Caruso P, Silva E, Teles JM, Lobo SM, Friedman G, Pizzol FD, Mello PV, Bozza FA, Silva UC, Torelly AP, Knibel MF, Rezende E, Netto JJ, Piras C, Castro AM, Ferreira BS, Réa-Neto Á, Olmedo PB, Salluh JI. Characteristics and outcomes of patients with cancer requiring admission to intensive care units: A prospective multicenter study. Critical Care Medicine. 2010;38:9-15.  https://doi.org/10.1097/CCM.0b013e3181c0349e
  19. Pène F, Percheron S, Lemiale V, Viallon V, Claessens YE, Marqué S, Charpentier J, Angus DC, Cariou A, Chiche JD, Mira JP. Temporal changes in management and outcome of septic shock in patients with malignancies in the intensive care unit. Critical Care Medicine. 2008;36(3):690-696.  https://doi.org/10.1097/CCM.0B013E318165314B
  20. Ñamendys-Silva SA, González-Herrera MO, Texcocano-Becerra J, Herrera-Gómez A. Clinical characteristics and outcomes of critically ill patients with septic shock. QJM: Monthly Journal of the Association of Physicians. 2011;104(6):505-511.  https://doi.org/10.1093/qjmed/hcq260
  21. de Montmollin E, Tandjaoui-Lambiotte Y, Legrand M, Lambert J, Mokart D, Kouatchet A, Lemiale V, Pène F, Bruneel F, Vincent F, Mayaux J, Chevret S, Azoulay E. Outcomes in critically ill cancer patients with septic shock of pulmonary origin. Shock. 2013;39(3):250-254.  https://doi.org/10.1097/SHK.0b013e3182866d32
  22. Lecuyer L, Chevret S, Thiery G, Darmon M, Schlemmer B, Azoulay E. The ICU trial: a new admission policy for cancer patients requiring mechanical ventilation. Critical Care Medicine. 2007;35(3):808-814.  https://doi.org/10.1097/01.CCM.0000256846.27192.7A
  23. Póvoa P, Souza-Dantas VC, Soares M, Salluh JF. C-reactive protein in critically ill cancer patients with sepsis: influence of neutropenia. Critical Care. 2011;15(3):R129. https://doi.org/10.1186/cc10242
  24. Gromova EG, Tuguz A, Kiselevskiy MV, Kuznetsova LS. Prognostic role of the main proinflammatory cytokines ratio in the blood, urine, drainage liquid and filtrates in the process of hemofiltration in cancer patients with multiple organ failure (MOF). 18th UICC International Cancer Congress in Oslo 2002, 30.06.02—05.07.02. Oslo; 2002:445. 
  25. Anisimova NYu, Gromova EG, Kuznetsova LS, Kiselevsky MV. Features of cytokinin-inducing activity and cytokine profile of blood in cancer patients with sepsis. Rossijskij immunologicheskij zhurnal. 2010;4(13)3:276-281. (In Russ.).
  26. Gogos CA, Drosou E, Bassaris HP, Skoutelis A. Pro-versus anti-inflammatory cytokine profile in patients with severe sepsis: a marker for prognosis and future therapeutic options. The Journal of Infectious Diseases. 2000; 181(1):176-180.  https://doi.org/10.1086/315214
  27. Taniguchi T. Cytokine-adsorbing columns. Contributions to Nephrology. 2010;166:134-141.  https://doi.org/10.1159/000314863
  28. Payen D, Mateo J, Cavaillon JM, Fraisse F, Floriot C, Vicaut E; Hemofiltration and Sepsis Group of the Collège National de Réanimation et de Médecine d’Urgence des Hôpitaux extra-Universitaires. Impact of continuous venovenous hemofiltration on organ failure during the early phase of severe sepsis: a randomized controlled trial. Critical Care Medicine. 2009;37(3):803-810.  https://doi.org/10.1097/CCM.0b013e3181962316
  29. De Pont A.C. Hemofiltration in the early phase of sepsis: friend or foe? Critical Care Medicine. 2009;37(3):1125-1126. https://doi.org/10.1097/CCM.0b013e3181987d2d
  30. Sakata H, Yonekawa M, Kawamura A. Blood purification therapy for sepsis. Transfusion and Apheresis Science. 2006;35(3):245-251.  https://doi.org/10.1016/j.transci.2006.06.003
  31. Johnson GB, Brunn GJ, Platt JL. Activation of mammalian Toll-like receptors by endogenous agonists. Critical Reviews in Immunology. 2003;23(1-2): 15-44.  https://doi.org/10.1615/critrevimmunol.v23.i12.20
  32. Gromova EG. Ekstrakorporal’nye metody detoksikatsii v kompleksnoj intensivnoj terapii onkologicheskikh bol’nykh: diss. ... dokt. med. nauk. M. 2004.
  33. Anisimova N, Kiselevsky M, Gromova E, Kuznetzova L. Elimination of cytokine and soluble cytokine receptors by carbon sorbents from blood. Critical Care. 2010;14(Suppl 2):52.  https://doi.org/10.1186/cc9155
  34. Soares M, Salluh JIF, Torres VBL, Leal JVR, Spector N. Short- and long-term outcomes of critically ill patients with cancer and prolonged ICU length of stay. Chest. 2008;134(3):520-526.  https://doi.org/10.1378/chest.08-0359
  35. Butler AM, Olshan AF, Kshirsagar AV, Edwards JK, Nielsen ME, Wheeler SB, Brookhart MA. Cancer incidence among US Medicare ESRD patients receiving hemodialysis. 1996-2009. American Journal of Kidney Diseases. 2015;65(5):763-772.  https://doi.org/10.1053/j.ajkd.2014.12.013
  36. Myint PT, Butt HW, Alrifai T, Marin C. Spontaneous Tumor Lysis Syndrome Secondary to Small-Cell Neuroendocrine Carcinoma of Unknown Origin: A Rare Case Report and Literature Review. Case Reports in Oncological Medicine. 2019;6375693. https://doi.org/10.1155/2019/6375693
  37. Calvo Villas JM. Tumor lysis syndrome. Medicina Clinica. 2019;152(10):397-404.  https://doi.org/10.1016/j.medcli.2018.10.029
  38. Nikoomanesh K., Choi J., Arabian S. Paraneoplastic syndrome as the presentation of limited stage small cell carcinoma. BMC Pulmonary Medicine. 2018;18(1):169.  https://doi.org/10.1186/s12890-018-0729-y
  39. Sioka C, Fotopoulos A, Kyritsis AP. Paraneoplastic immune-mediated neurological effects of systemic cancers. Expert Review of Clinical Immunology. 2014;10(5):621-630.  https://doi.org/10.1586/1744666X.2014.901151
  40. Yiu VW, Kovithavongs T, McGonigle LF, Ferreira P. Plasmapheresis as an effective treatment for idiopathic opsoklonus-myoclonus syndrome. Pediatric Neurology. 2001;24(1):72-74.  https://doi.org/10.1016/s0887-8994(00)00227-7
  41. Kamyshov SV. Methods of extracorporeal immunopharmacotherapy: from General clinical to oncological practice. Vestnik Natsional’nogo mediko-khirurgicheskogo tsentra imeni N.I. Pirogova. 2018;13(3):126-131. (In Russ.). https://doi.org/10.25881/BPNMSC.2018.19.77.027
  42. Aigner KR, Selak E, Gailhofer S. Isolated thoracic perfusion with chemofiltration for progressive malignant pleural mesothelioma. OncoTargets and Therapy. 2017;10:3049-3057. https://doi.org/10.2147/OTT.S134126
  43. Levi M. Disseminated Intravascular Coagulation in Cancer: An Update. Seminars in Thrombosis and Hemostasis. 2019;45(4):342-347.  https://doi.org/10.1055/s-0039-1687890
Contact the author
Email
Message
The publishing house "Media Sphere" does not provide treatment services, does not give recommendations on contacting medical institutions and specific specialists, on the prescription of medicines and dietary supplements.

Email Confirmation

An email was sent to test@gmail.com with a confirmation link. Follow the link from the letter to complete the registration on the site.

Email Confirmation

Submit Application

You can become an author of one of our magazines, send a request and we will consider it in during the day.

Name
Phone
E-mail
Message
Login
Registration
E-mail
Password
Forgot Password?

Log in to the site using your account in one of the services

Password recovery
E-mail
Login
Register

We use cооkies to improve the performance of the site. By staying on our site, you agree to the terms of use of cооkies. To view our Privacy and Cookie Policy, please. click here.